Catalyst PharmaceuticalsCPRX

那斯達克 · USD
24.18
+0.56
(+2.37%)
收盤 12/16 04:59 (UTC+8)
盤後 
24.18 
24.18 
(0.00%)
12/16 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 1.00
  • 1.03
  • 1.11
  • 0.99
  • 1.23
  • 1.29
  • 1.42
  • 1.41
  • 1.47
  • 1.48
icon
  • 16.65
  • 3.12
  • 7.67
  • -10.91
  • 24.57
  • 4.88
  • 10.20
  • -0.28
  • 3.64
  • 1.25
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
148,392
146,563
141,421
141,820
128,695
122,710
98,509
110,568
102,688
99,582
營業成本
22,65420,61417,91121,64319,27715,40512,52015,80914,16712,045
營業毛利
125,738
125,949
123,510
120,177
109,418
107,305
85,989
94,759
88,521
87,537
營業費用
59,47159,651---53,059-53,067125,70940,838
研發費用
2,6574,3583,8873,7983,2842,9852,5811,97283,6623,954
推銷及管理費用
47,47045,94946,91144,19245,88040,73046,93842,03633,56028,396
非經常性項目費用
----------
其他營業費用
9,3449,3449,3459,3449,3459,3449,3449,0598,4878,488
營業利益
66,267
66,298
63,367
62,843
50,909
54,246
27,126
41,692
-37,188
46,699
其他收入及費用
4,7682,9957,91911,3386,2961,5421,9635,015-8331,813
利息費用
----------
稅前純益
71,035
69,293
71,286
74,181
57,205
55,788
29,089
46,707
-38,021
48,512
所得稅
18,25217,18514,54918,24513,32114,9945,81411,863-7,25710,750
稅後純益
52,783
52,108
56,737
55,936
43,884
40,794
23,275
34,844
-30,764
37,762
基本每股稅後盈餘(元)
0.430.430.470.470.370.350.20--0.290.36
稀釋每股稅後盈餘(元)
0.410.410.450.440.350.330.190.31-0.270.33
基本平均股數(千股)
122600.00122163.00121472.00119892.00118931.00118180.00116806.00-106568.00106258.00
稀釋平均股數(千股)
127090.00127543.00126957.00126280.00125407.00124655.00123403.00-106568.00113673.00
還原基本每股稅後盈餘(元)
0.430.430.470.470.370.350.20--0.290.36
還原稀釋每股稅後盈餘(元)
0.410.410.450.440.350.330.190.31-0.270.33
還原基本平均股數(千股)
122,600122,163121,472119,892118,931118,180116,806-106,568106,258
還原稀釋平均股數(千股)
127,090127,543126,957126,280125,407124,655123,403-106,568113,673
EBITDA(千元)
80,35578,67580,68683,60065,57365,35738,67256,024-28,30757,082

大家都在看

HOT